Bruce Linton, co-founder and former CEO of Canopy Growth Corp. is taking positions at CBD pet food and psychedelic medicine companies. He has also become executive chairman of Michigan-based Gage Cannabis since Canopy fired him him at the beginning of July.
Linton grew Canopy to become one of Canada’s biggest licensed producers.
- He is becoming an activist investor — “the good kind” he says — in pot companies Slang Worldwide and DNA Genetics.
- He says he chose this group of companies to be diversified geographically and by category.
- Linton gave an exit interview to the WeedWeek podcast this summer.
- He liked the Canadian psychedelic company, Mind Medicine because it is developing drugs for FDA approval. He predicts intellectual property in the nascent space will focus on dose control. It is developing a product to treat opioid addiction.
And Cannabis Wire has the scoop on what Canopy Growth told the Trump administration on hemp regulations.